Skip to content

13F-HR filed by Nan Fung Group Holdings Ltd

Nan Fung Group Holdings Ltd filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 21:14:59 UTC, with 29 holding rows worth $149,667,138.

Accession
0001012975-26-001047
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A combination report, 29 entries on the cover page, a total value of $149,667,138 stated on the cover page (in dollars after the unit check, H1), rows summing to $149,667,138 with VALUE read as dollars as filed, 13F file number 028-21371. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LB PHARMACEUTICALS INC50180M108COMMON STOCK630,657$24,204,616dollars as filed
MAPLIGHT THERAPEUTICS INC56565P103COMMON STOCK2,300,328$23,440,342dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share918,765$12,614,643dollars as filed
CYBIN INC23256X407COM NEW987,222$12,132,958dollars as filed
EVOMMUNE INC30054Y107COMMON STOCK1,441,032$11,902,924dollars as filed
NUVATION BIO INC COM CL A67080N101Stock1,327,224$7,432,454dollars as filed
INCYTE CORP COM45337C102Stock53,742$6,521,592dollars as filed
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR15,722$5,753,309dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM49,120$4,676,961dollars as filed
PROCORE TECHNOLOGIES INC COM74275K108Stock88,832$4,594,391dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK164,986$4,012,460dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock19,253$3,951,871dollars as filed
KYMERA THERAPEUTICS INC501575104COM30,875$3,451,516dollars as filed
ASCENDIS PHARMA A/SK08588103ORD SHS *A*13,600$3,098,488dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock5,672$2,858,461dollars as filed
OCULIS HOLDING AGH5870P102CMN300,565$2,807,277dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR2,800$2,684,948dollars as filed
TCGX ACQUISITION CORPG8708J109COM200,000$2,502,000dollars as filed
CELCUITY INC15102K100COM28,300$2,250,416dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM102,984$2,075,128dollars as filed
Braveheart Bio Inc10567X101COM81,376$1,643,795dollars as filed
HARMONY BIOSCIENCES HLDGS IN413197104COM27,049$1,061,944dollars as filed
iShares Ethereum Trust46438R105COM50,549$1,017,046dollars as filed
IShares Bitcoin Trust Registered46438F101SHS15,968$755,925dollars as filed
INSMED INC COM PAR $.01457669307Stock6,580$751,041dollars as filed
RECURSION PHARMACEUTICALS IN75629V104CL A181,631$750,136dollars as filed
RANI THERAPEUTICS HLDGS INC753018100CMN493,584$390,425dollars as filed
ENTRADA THERAPEUTICS INC COM29384C108Stock49,082$311,671dollars as filed
BOLT BIOTHERAPEUTICS INC097702203COM NEW5,000$18,400dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-26-001047this filing2026-11-13